Literature DB >> 26057367

The active role of osteoporosis in the interaction between osteoblasts and bone metastases.

Stefania Pagani1, Milena Fini2, Gianluca Giavaresi2, Francesca Salamanna3, Veronica Borsari3.   

Abstract

INTRODUCTION: To minimize the severity of bone metastases and to delay their onset, it is important to analyze the underlying biological mechanisms. The present study focused on the link between OP and metastatic cells, with particular attention to osteoblast behavior.
METHODS: Osteoblasts (OB) were isolated from the trabecular bone of iliac crest of healthy (SHAM) and ovariectomized (OVX) adult female rats and co-cultured with MRMT-1 rat breast carcinoma cells as conditioned medium (CM) or alone (CTR) for 24h, 7 and 14 days and tested for cell viability, morphology and synthetic activity, i.e. C-terminal procollagen type I, alkaline phosphatase, osteoprotegerin, receptor activator for nuclear factor KB ligand and interleukin-8.
RESULTS: Osteoblast morphology showed a reduced organization in the OVX group, in particular in the CM condition. Conversely, the analysis of cell viability revealed significantly higher values in the OVXCM group with respect to the SHAMCM group at all experimental times, whereas the OVXCTR group had significantly lower values at 7 and 14 days in comparison to those of the SHAM group. ALP release was significantly lower in the CM condition than that of CTR at all timepoints, and so was procollagen type I at 7 and 14 days. The RANKL/OPG ratio showed significantly higher values in OVX osteoblasts in comparison with those of the SHAM group, both in CTR and in CM conditions at each experimental time. Finally, OVXCM showed significantly higher values of IL-8 than those of SHAMCM at 7 and 14 days.
CONCLUSIONS: The results clearly indicate an influence of the metastatic cells on the osteoblastic physiology at different levels: morphology, viability, release of typical proteins, and also IL-8 as a proinflammatory cytokine, especially marked by osteoporosis. Further investigations might highlight the relationship between osteoblasts and breast cancer cells, which might be useful to improve common drugs used against osteoporosis and bone metastases, by enhancing the bone deposition/tumor progression ratio.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer cells; Metastasis; Osteoblasts; Osteoporosis

Mesh:

Year:  2015        PMID: 26057367     DOI: 10.1016/j.bone.2015.06.002

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  9 in total

1.  The prognostic and predictive role of hyponatremia in patients with advanced non-small cell lung cancer (NSCLC) with bone metastases.

Authors:  S Rinaldi; M Santoni; G Leoni; I Fiordoliva; G Marcantognini; T Meletani; G Armento; D Santini; T Newsom-Davis; M Tiberi; F Morgese; M Torniai; M Bower; Rossana Berardi
Journal:  Support Care Cancer       Date:  2018-11-08       Impact factor: 3.603

2.  Relevance of humanized three-dimensional tumor tissue models: a descriptive systematic literature review.

Authors:  D Contartese; Francesca Salamanna; F Veronesi; M Fini
Journal:  Cell Mol Life Sci       Date:  2020-04-13       Impact factor: 9.261

3.  CD31hiEmcnhi Vessels Support New Trabecular Bone Formation at the Frontier Growth Area in the Bone Defect Repair Process.

Authors:  Jimeng Wang; Yi Gao; Pengzhen Cheng; Donglin Li; Huijie Jiang; Chuanlei Ji; Shuaishuai Zhang; Chao Shen; Junqin Li; Yue Song; Tianqing Cao; Chunmei Wang; Liu Yang; Guoxian Pei
Journal:  Sci Rep       Date:  2017-07-10       Impact factor: 4.379

4.  An in vitro 3D bone metastasis model by using a human bone tissue culture and human sex-related cancer cells.

Authors:  Francesca Salamanna; Veronica Borsari; Silvia Brogini; Gianluca Giavaresi; Annapaola Parrilli; Simona Cepollaro; Matteo Cadossi; Lucia Martini; Antonio Mazzotti; Milena Fini
Journal:  Oncotarget       Date:  2016-11-22

5.  Stability and survival analysis of elderly patients with osteolytic spinal bone metastases after palliative radiotherapy : Results from a large multicenter cohort.

Authors:  Tilman Bostel; Robert Förster; Ingmar Schlampp; Tanja Sprave; Sati Akbaba; Daniel Wollschläger; Jürgen Debus; Arnulf Mayer; Heinz Schmidberger; Harald Rief; Nils Henrik Nicolay
Journal:  Strahlenther Onkol       Date:  2019-06-25       Impact factor: 3.621

Review 6.  What Is the Role of Interleukins in Breast Cancer Bone Metastases? A Systematic Review of Preclinical and Clinical Evidence.

Authors:  Francesca Salamanna; Veronica Borsari; Deyanira Contartese; Viviana Costa; Gianluca Giavaresi; Milena Fini
Journal:  Cancers (Basel)       Date:  2019-12-13       Impact factor: 6.639

Review 7.  Biological Deciphering of the "Kidney Governing Bones" Theory in Traditional Chinese Medicine.

Authors:  Hanmin Zhu; Qi Liu; Wei Li; Shuming Huang; Bo Zhang; Yumei Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-29       Impact factor: 2.629

Review 8.  A systematic review on in vitro 3D bone metastases models: A new horizon to recapitulate the native clinical scenario?

Authors:  Francesca Salamanna; Deyanira Contartese; Melania Maglio; Milena Fini
Journal:  Oncotarget       Date:  2016-07-12

9.  Multiple Effects of Resveratrol on Osteosarcoma Cell Lines.

Authors:  Angela De Luca; Daniele Bellavia; Lavinia Raimondi; Valeria Carina; Viviana Costa; Milena Fini; Gianluca Giavaresi
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.